UNSPSC 51144103: Amfetamine or amphetamine

This classification denotes a cns stimulant with the molecular formula C9H13N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CK833KGX7E, chemically known as phenethylamine, d-.alpha.-methyl- but more generally known as amfetamine, which bears US NIH Compound Identifier 3007. European Medicines Agency schedules Amfetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05418MIG.

UNSPSC 51144103 Amphetamine or amphetamine (Commodity) does not align with the state and local procurement activity tagged under this code. The three recent opportunities span naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription program design (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and over-the-counter products (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations involve the procurement or distribution of controlled-substance stimulants. The mismatch suggests either miscoding by issuing bodies or a tagging error in the underlying records.

The geographic spread of recorded activity spans Florida, Texas, and Minnesota, with the most substantive recent solicitation being the MMCAP RFP for generic pharmaceuticals and OTC products posted January 20, 2026, with proposals due March 26, 2026. This is a cooperative purchasing vehicle administered by the Minnesota Department of Administration, distributing awards across multiple state and local jurisdictions including Oregon, with authorization to use three wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson). The Seminole County IFB for naloxone and drug deactivation systems (posted June 30, 2026, due July 26, 2026) targets a public health use case unrelated to amphetamine procurement. The Texas HHS RFI (posted April 3, 2026) seeks market intelligence on direct manufacturer relationships for prescriptions. The code shows minimal recent activity relevant to controlled-substance stimulant procurement under state and local contracts.